|
|
||||||||
by A2- and
A3-adenosine
receptors
1 Cardiovascular Institute and 2 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213
The proinflammatory cytokines tumor necrosis
factor (TNF)-
and interleukin (IL)-6 have been implicated in the
development of congestive heart failure. Adenosine inhibits the
expression of TNF-
and IL-6 in macrophages. We determined the effect
of adenosine on cytokine expression in rat cardiomyocytes and
trabecular muscles obtained from patients with cardiomyopathy. In
myocytes, adenosine suppressed TNF-
mRNA by 40%
(P < 0.05) and induced a 4.7-fold
increase in IL-6 mRNA (P < 0.05)
with a twofold increase in IL-6 protein release
(P < 0.001). The effect on TNF-
could be replicated by A2 agonist.
The effect on IL-6 could be replicated by
A3 agonist, but not by
A1 and
A2 agonists, and was completely suppressed by A3 antagonist. In
human trabecular muscles, A2
agonist suppressed TNF-
mRNA by 60%
(P < 0.05), but adenosine had no effect on IL-6. In the failing heart, IL-6 was immunolocalized to
inflammatory cells. Thus A2 and
A3 receptors differentially regulate cardiac expression of TNF-
and IL-6. Rat cardiomyocytes and
the failing human heart respond differently to adenosine.
interleukin-1
; interleukin-6; tumor necrosis factor-
; congestive heart failure
This article has been cited by other articles:
![]() |
N. Smart, M. H. Mojet, D. S. Latchman, M. S. Marber, M. R. Duchen, and R. J. Heads IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes Cardiovasc Res, January 1, 2006; 69(1): 164 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang, R. Zheng, S. Hu, Y. Ma, M. A. Choudhry, J. L. Messina, L. W. Rue III, K. I. Bland, and I. H. Chaudry Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2183 - H2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kudo, Y. Wang, M. Xu, A. Ayub, and M. Ashraf Adenosine A1 receptor mediates late preconditioning via activation of PKC-delta signaling pathway Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H296 - H301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H339 - H345. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kadokami, C. F. McTiernan, T. Kubota, C. S. Frye, G. S. Bounoutas, P. D. Robbins, S. C. Watkins, and A. M. Feldman Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2281 - H2291. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |